交易所数据显示，11月24日，戴维医疗收盘13.17元，上涨2.01%，滚动市盈率PE（当前股价与前四季度 每股收益总和的比值）达到56.97倍，总市值37.93亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均52.19倍，行业中值40.14倍，戴维医疗排 名第95位。 资金流向方面，11月24日，戴维医疗主力资金净流出72.24万元，近5日总体呈流出状态，5日共流出 983.66万元。 最新一期业绩显示，2025年三季报，公司实现营业收入3.93亿元，同比减少2.55%；净利润7261.78万 元，同比增加14.71%，销售毛利率56.43%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13戴维医疗56.9766.243.1137.93亿行业平均 52.1952.084.44109.78亿行业中值40.1437.372.7954.98亿1九安医疗10.2111.560.87192.85亿2康德莱 15.2317.241.3937.13亿3英科医疗15.4517.951.45263.10亿4奥美医疗15.5519.081.8970.36亿5维力医疗 15.7817.571.9938. ...

Core Viewpoint - David Medical's stock price increased by 5.38% to 15.47 yuan, reflecting positive market sentiment despite a decline in revenue [1] Financial Performance - In the first half of 2025, David Medical reported a revenue of 251 million yuan, a year-on-year decrease of 5.48% [1] - The net profit attributable to shareholders was 50.98 million yuan, showing a year-on-year increase of 9.57% [1] Stock Market Activity - The opening price was 15.76 yuan, with a high of 16.95 yuan and a low of 15.22 yuan, indicating volatility during the trading session [1] - The trading volume reached 352,300 hands, with a total transaction value of 562 million yuan [1] - On the same day, there was a net inflow of 15.86 million yuan from main funds, accounting for 0.71% of the circulating market value [1] - Over the past five days, the net inflow from main funds totaled 9.63 million yuan, representing 0.43% of the circulating market value [1] Company Overview - David Medical operates in the medical device sector, focusing on the research, production, and sales of obstetric and pediatric care equipment, as well as minimally invasive surgical instruments [1] - The company is also expanding its product offerings to include emergency surgical ICU products [1] Corporate Governance - The fifth supervisory board's thirteenth meeting approved multiple proposals, indicating ongoing corporate governance activities [1]

8月22日，戴维医疗今日收盘15.47元，上涨5.38%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到72.19倍，总市值44.55亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均56.95倍，行业中值40.49倍，戴维医疗排 名第95位。 股东方面，截至2025年8月20日，戴维医疗股东户数22900户，较上次增加400户，户均持股市值35.28万 元，户均持股数量2.76万股。 宁波戴维医疗器械股份有限公司的主营业务是儿产科保育设备、微创外科手术器械等产品的研发、生产 和销售。公司的主要产品是儿产科保育设备、微创外科手术器械、急救手术ICU产品。截至报告期末， 公司及子公司累计拥有专利257项，其中发明专利70项、实用新型专利138项、外观设计专利49项，计算 机软件著作权9项。 最新一期业绩显示，2025年半年报，公司实现营业收入2.51亿元，同比-5.48%；净利润5097.67万元，同 比9.57%，销售毛利率58.40%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13戴维医疗72.1977.803.7244.55亿行业平均 56.9554.955.111 ...

Group 1 - As of August 21, David Medical's stock price closed at 14.68 yuan, down 0.94% from the previous trading day, with a trading volume of 75,116 hands and a transaction amount of 111 million yuan [1] - David Medical focuses on the research, production, and sales of medical devices, with its main business covering three areas: obstetric and neonatal care equipment, minimally invasive surgical instruments, and emergency surgical ICU products. The medical device manufacturing sector accounted for 98.08% of the company's revenue in the 2024 annual report [1] - On August 21, the company announced that the fifth session of the thirteenth board of directors approved the proposal regarding the full text and summary of the 2025 semi-annual report. The semi-annual report showed that in the first half of 2025, the company achieved operating revenue of 251 million yuan, a year-on-year decrease of 5.48%, while the net profit attributable to shareholders of the listed company was 50.98 million yuan, a year-on-year increase of 9.57%. Notably, the second quarter performance was strong, with a year-on-year growth of 237.4% in net profit attributable to the parent [1] Group 2 - On August 21, David Medical saw a net inflow of main funds amounting to 2.7751 million yuan, with a cumulative net inflow of 2.1627 million yuan over the past five days [2]